Javascript must be enabled for the correct page display
Skip to Content
Events

CPHI Milan 2026

October 6-8, 2026
Fiera Milano, Italy

We’re excited to be joining Bora Pharmaceuticals at CPHI Milan at Booth #12C49 – Hall 12!

Join the Bora Biologics team at CPHI Milan to explore biologics development and manufacturing strategies designed to reduce program risk, support smoother tech transfer, and strengthen supply continuity from clinical development through commercial manufacturing.

Helping You Build A Lower-Risk Biologics Manufacturing Strategy
At CPHI Milan, discover how Bora Biologics combines technical biologics expertise, regulatory experience, and reliable execution to support complex biologic programs with confidence. With capabilities spanning process development, analytical support, technology transfer, GMP manufacturing, and commercial biologics supply, Bora Biologics helps customers advance programs while managing the operational, regulatory, and timeline risks that can impact long-term success.

Bora Biologics continues to expand its role as a trusted CDMO partner for biologics innovators. Through the addition of the Rockville, Maryland biologics manufacturing facility, Bora Biologics strengthens its North American manufacturing presence and brings inspection-proven infrastructure, experienced teams, and established GMP systems to support biologics programs from development through commercial supply.

Whether you’re preparing for tech transfer, scaling a clinical program, addressing manufacturability challenges, or planning for commercial readiness, connect with our team to discuss your goals and explore how Bora Biologics can support your biologics program.

If you need a biologics CDMO partner with mammalian and microbial expertise, we encourage you to connect with us in advance or at the show.

Meet With Bora Biologics At CPHI Milan 2026
Marc Goemans, Chief Commercial Officer, is currently accepting meetings for CPHI Milan. Let’s discuss how to build a biologics manufacturing strategy that supports not only batch execution, but long-term program success.

Marc Goemans, MSc, MBA
Chief Commercial Officer
Bora Biologics

✅ Request received. We will connect with you shortly to schedule a meeting.







    Bora Biologics

    the logical choice

    Join the ranks of biopharma pioneers who trust us.
    Explore how we minimize risks and accelerate your success.

    Partner with us

    Client-Centric

    100% commitment to supporting your success

    We have been the client, bringing multiple biologics from IND to BLA. Your needs and goals are at the forefront of our approach. By involving you in every step of the process, we ensure transparency and alignment, reducing the likelihood of misunderstandings and ensuring the outcome meets your expectations.

    Experience

    15+ years developing & manufacturing biologics

    We have honed our ability to navigate complexities. Our track record from concept to commercialization means we can apply best practices and lessons learned, ensuring smoother project execution.

    Expertise

    Over 200 seasoned scientists & regulatory professionals

    Our team exudes deep knowledge and specialized skills. This expertise allows us to foresee potential challenges and implement proactive solutions, reducing the likelihood of setbacks.

    Commercial-Ready

    2 US FDA registered GMP manufacturing facilities

    We focus on delivering solutions that are ready for market. With clinical to commercial scale facilities consistently meeting compliance standards, we ensure your project is primed for success, minimizing the risk of costly revisions or delays.

    Allied

    access to global CDMO resources

    Our partnership with Bora Pharmaceuticals provides additional resources and insights. This network enables us to leverage shared knowledge and expertise, further mitigating risks and accelerating the overall success of your project.